Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2025-12-24 @ 11:39 PM
NCT ID:
NCT02830451
Brief Summary:
The registry aims to collect patient information such as patient demographics, co-morbidities, clinical, diagnostic, and therapeutic data, as well as information on adverse events and HRQOL outcomes specific for patients with metastatic spine tumor(s).
Detailed Description:
To prospectively determine the prognostic variables (clinical, diagnostic, and therapeutic) within patients diagnosed with metastatic spine tumor(s) that are associated with:
* patient reported outcomes (HRQOL)
* morbidity data
* local tumor control
* survival
Outcome measures:
Variables which will be collected in the registry that are applicable to patients with metastatic spine tumor include:
* • Patient details
* Details of previous treatment
* Diagnosis
* Symptoms
* Treatment details for the index target
* Imaging information
The following outcome measures will be collected:
* Patient reported outcomes:
* Euroqol EQ-5D-3L
* Euroqol EQ-5D VAS - Quality of Life
* Neck Pain Numeric Rating Scale (NRS)
* Arm Pain NRS
* Back Pain NRS
* Leg Pain NRS
* SOSGOQ
* Patient assessment
* Ambulation
* Pain medication
* Nutritional Status Tool (PG-SGA©)
* Morbidity data
* Local disease recurrence data
* Overall survival data
Study:
NCT02830451
Study Brief:
Protocol Section:
NCT02830451